BIOMARKER:

CD8 expression

Entrez ID:

Related biomarkers:

‹

›

CD8 expression CD8 expression	Prostate Cancer Prostate Cancer	CD8 expression CD8 expression	Prostate Cancer Prostate Cancer	atezolizumab + enzalutamide capsule Sensitive: B - Late Trials	atezolizumab + enzalutamide capsule Sensitive: B - Late Trials
CD8 expression CD8 expression	Melanoma Melanoma	CD8 expression CD8 expression	Melanoma Melanoma	pembrolizumab Sensitive: C2 – Inclusion Criteria	pembrolizumab Sensitive: C2 – Inclusion Criteria
CD8 expression CD8 expression	Urothelial Cancer Urothelial Cancer	CD8 expression CD8 expression	Urothelial Cancer Urothelial Cancer	PF-06801591 Sensitive: C3 – Early Trials	PF-06801591 Sensitive: C3 – Early Trials
CD8 expression CD8 expression	Melanoma Melanoma	CD8 expression CD8 expression	Melanoma Melanoma	nivolumab Sensitive: C3 – Early Trials	nivolumab Sensitive: C3 – Early Trials
CD8 expression CD8 expression	Melanoma Melanoma	CD8 expression CD8 expression	Melanoma Melanoma	ipilimumab Sensitive: C3 – Early Trials	ipilimumab Sensitive: C3 – Early Trials
CD8 expression CD8 expression	Renal Cell Carcinoma RCC	CD8 expression CD8 expression	Renal Cell Carcinoma RCC	nivolumab Sensitive: C3 – Early Trials	nivolumab Sensitive: C3 – Early Trials
CD8 expression CD8 expression	Solid Tumor Solid Tumor	CD8 expression CD8 expression	Solid Tumor Solid Tumor	TAB004 Sensitive: C3 – Early Trials	TAB004 Sensitive: C3 – Early Trials